Giulia Buzzatti

477 total citations
23 papers, 270 citations indexed

About

Giulia Buzzatti is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Giulia Buzzatti has authored 23 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Giulia Buzzatti's work include BRCA gene mutations in cancer (4 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). Giulia Buzzatti is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). Giulia Buzzatti collaborates with scholars based in Italy, United States and United Kingdom. Giulia Buzzatti's co-authors include Francesco Boccardo, Lucia Del Mastro, Chiara Dellepiane, A. Rubagotti, Francesco Ricci, Carlo Messina, Carlo Cattrini, Marco Messina, Elisa Zanardi and Luigi Cerbone and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Giulia Buzzatti

22 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Buzzatti Italy 8 146 90 76 61 49 23 270
Florentine Hilbers Belgium 13 241 1.7× 81 0.9× 187 2.5× 101 1.7× 9 0.2× 32 411
Ana T. Nunes United States 11 275 1.9× 70 0.8× 52 0.7× 120 2.0× 81 1.7× 19 455
Ajit Paintal United States 12 99 0.7× 128 1.4× 55 0.7× 91 1.5× 31 0.6× 24 333
Raffaele Piscitelli Italy 8 87 0.6× 149 1.7× 74 1.0× 146 2.4× 18 0.4× 18 336
Cyril Abdeddaim France 10 302 2.1× 92 1.0× 88 1.2× 77 1.3× 66 1.3× 30 519
Yuichi Ando Japan 9 130 0.9× 76 0.8× 32 0.4× 119 2.0× 32 0.7× 47 301
Sabine de Ducla Switzerland 7 307 2.1× 140 1.6× 88 1.2× 77 1.3× 20 0.4× 22 394
Amy Sullivan United States 6 258 1.8× 160 1.8× 87 1.1× 110 1.8× 124 2.5× 16 380
M Tomšová Czechia 7 251 1.7× 61 0.7× 47 0.6× 32 0.5× 190 3.9× 22 387
Yang Jiao China 10 129 0.9× 32 0.4× 178 2.3× 196 3.2× 56 1.1× 20 383

Countries citing papers authored by Giulia Buzzatti

Since Specialization
Citations

This map shows the geographic impact of Giulia Buzzatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Buzzatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Buzzatti more than expected).

Fields of papers citing papers by Giulia Buzzatti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Buzzatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Buzzatti. The network helps show where Giulia Buzzatti may publish in the future.

Co-authorship network of co-authors of Giulia Buzzatti

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Buzzatti. A scholar is included among the top collaborators of Giulia Buzzatti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Buzzatti. Giulia Buzzatti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perachino, Marta, Lucia Del Mastro, Giulia Buzzatti, et al.. (2025). Different activity and toxicity of immunotherapy in monozygotic twins diagnosed with early triple-negative breast cancer: a case report. Therapeutic Advances in Medical Oncology. 17. 12742301–12742301. 1 indexed citations
2.
Varesco, Liliana, Stefania Sciallero, Daniela Turchetti, et al.. (2024). Cascade genetic testing in hereditary cancer: exploring the boundaries of the Italian legal framework. Familial Cancer. 24(1). 9–9. 1 indexed citations
3.
Borea, Roberto, Bárbara Cardinali, Luca Arecco, et al.. (2024). 83P Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in eary high risk breast cancer: The CITUCEL trial update. Annals of Oncology. 35. S247–S247. 1 indexed citations
4.
Arecco, Luca, Giulia Buzzatti, Piero Fregatti, et al.. (2024). Fertility and Pregnancy-Related Issues in Young BRCA Carriers With Breast Cancer. Breast Cancer Basic and Clinical Research. 18. 781999989–781999989. 1 indexed citations
5.
Battistuzzi, Linda, Eva Blondeaux, Francesca Poggio, et al.. (2024). Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer. BMC Palliative Care. 23(1). 129–129.
6.
Paudice, Michele, Floriana Valentino, Paola Roggieri, et al.. (2023). The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis. Journal of Clinical Medicine. 12(23). 7236–7236. 2 indexed citations
7.
Blondeaux, Eva, Luca Arecco, Kevin Punie, et al.. (2023). Germline TP53 pathogenic variants and breast cancer: A narrative review. Cancer Treatment Reviews. 114. 102522–102522. 25 indexed citations
8.
Godino, Lea, Linda Battistuzzi, Giulia Buzzatti, et al.. (2023). Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?. Familial Cancer. 23(2). 197–207. 7 indexed citations
9.
Cardinali, Bárbara, Roberta Tasso, Simona Coco, et al.. (2022). Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer. International Journal of Molecular Sciences. 23(11). 6320–6320. 7 indexed citations
10.
Conte, Benedetta, Filippo Montemurro, Alessia Levaggi, et al.. (2022). Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial. Tumori Journal. 109(1). 71–78. 3 indexed citations
11.
Tini, Giacomo, Pietro Ameri, Giulia Buzzatti, et al.. (2021). Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer. Frontiers in Cardiovascular Medicine. 8. 654728–654728. 7 indexed citations
12.
Molinelli, Chiara, Lucia Del Mastro, S. Giraudi, et al.. (2020). 226P Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study. Annals of Oncology. 31. S331–S331. 1 indexed citations
13.
Blondeaux, Eva, Matteo Lambertini, Andrea Michelotti, et al.. (2020). Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study. British Journal of Cancer. 122(11). 1611–1617. 11 indexed citations
14.
Buzzatti, Giulia, Chiara Dellepiane, & Lucia Del Mastro. (2019). New emerging targets in cancer immunotherapy: the role of GITR. ESMO Open. 4(Suppl 3). e000738–e000738. 52 indexed citations
15.
Messina, Carlo, Carlo Cattrini, Giulia Buzzatti, et al.. (2018). CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials. Breast Cancer Research and Treatment. 172(1). 9–21. 51 indexed citations
16.
Cattrini, Carlo, Chiara Dellepiane, Alessia Cavo, et al.. (2016). Immunotherapy for genitourinary cancer. Anti-Cancer Drugs. 27(7). 585–599. 3 indexed citations
17.
Messina, Carlo, Giulia Buzzatti, Chiara Dellepiane, et al.. (2016). Genitourinary tumours in the targeted therapies era. Anti-Cancer Drugs. 27(10). 917–943. 9 indexed citations
18.
Bruzzone, Milena, Chiara Dellepiane, Alessia Cavo, et al.. (2016). Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study.. Journal of Clinical Oncology. 34(15_suppl). 5529–5529. 1 indexed citations
19.
Nuzzo, Pier Vitale, Giulia Buzzatti, Francesco Ricci, et al.. (2014). Periostin: A Novel Prognostic and Therapeutic Target For Genitourinary Cancer?. Clinical Genitourinary Cancer. 12(5). 301–311. 44 indexed citations
20.
Ricci, Francesco, Giulia Buzzatti, A. Rubagotti, & Francesco Boccardo. (2014). Safety of antiandrogen therapy for treating prostate cancer. Expert Opinion on Drug Safety. 13(11). 1483–1499. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florentine Hilbers Breakdown of academic impact, for papers by Ana T. Nunes Breakdown of academic impact, for papers by Ajit Paintal Breakdown of academic impact, for papers by Raffaele Piscitelli Breakdown of academic impact, for papers by Cyril Abdeddaim Breakdown of academic impact, for papers by Yuichi Ando Breakdown of academic impact, for papers by Sabine de Ducla Breakdown of academic impact, for papers by Amy Sullivan Breakdown of academic impact, for papers by M Tomšová Breakdown of academic impact, for papers by Yang Jiao
Rankless by CCL
2026